Amar Natarajan
Amar Natarajan
Email verificata su - Home page
Citata da
Citata da
Effect of supplementation of Bacillus subtilis LS 1-2 to broiler diets on growth performance, nutrient retention, caecal microbiology and small intestinal morphology
S Sen, SL Ingale, YW Kim, JS Kim, KH Kim, JD Lohakare, EK Kim, HS Kim, ...
Research in Veterinary Science 93 (1), 264-268, 2012
Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases
B Mohapatra, G Ahmad, S Nadeau, N Zutshi, W An, S Scheffe, L Dong, ...
Biochimica Et Biophysica Acta (BBA)-Molecular Cell Research 1833 (1), 122-139, 2013
Novel arylsulfoanilide− oxindole hybrid as an anticancer agent that inhibits translation initiation
A Natarajan, Y Guo, F Harbinski, YH Fan, H Chen, L Luus, J Diercks, ...
Journal of medicinal chemistry 47 (21), 4979-4982, 2004
3, 3-Diaryl-1, 3-dihydroindol-2-ones as antiproliferatives mediated by translation initiation inhibition
A Natarajan, YH Fan, H Chen, Y Guo, J Iyasere, F Harbinski, WJ Christ, ...
Journal of medicinal chemistry 47 (8), 1882-1885, 2004
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)
CM Robb, JI Contreras, S Kour, MA Taylor, M Abid, YA Sonawane, ...
Chemical communications 53 (54), 7577-7580, 2017
Cyclin dependent Kinase 9 inhibitors for cancer therapy: miniperspective
YA Sonawane, MA Taylor, JV Napoleon, S Rana, JI Contreras, ...
Journal of medicinal chemistry 59 (19), 8667-8684, 2016
Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers
SM Raja, RJ Clubb, C Ortega-Cava, SH Williams, TA Bailey, L Duan, ...
Cancer biology & therapy 11 (2), 263-276, 2011
Synthesis and biological evaluation of thiazolidine-2, 4-dione and 2, 4-thione derivatives as inhibitors of translation initiation
H Chen, YH Fan, A Natarajan, Y Guo, J Iyasere, F Harbinski, L Luus, ...
Bioorganic & medicinal chemistry letters 14 (21), 5401-5405, 2004
Isatin derived spirocyclic analogues with α-methylene-γ-butyrolactone as anticancer agents: a structure–activity relationship study
S Rana, EC Blowers, C Tebbe, JI Contreras, P Radhakrishnan, S Kizhake, ...
Journal of medicinal chemistry 59 (10), 5121-5127, 2016
Small molecule adenosine 5′-monophosphate activated protein kinase (AMPK) modulators and human diseases
S Rana, EC Blowers, A Natarajan
Journal of medicinal chemistry 58 (1), 2-29, 2015
RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment
AL Hein, CM Post, YM Sheinin, I Lakshmanan, A Natarajan, CA Enke, ...
Oncogene 35 (49), 6319-6329, 2016
Structure–activity requirements for the antiproliferative effect of troglitazone derivatives mediated by depletion of intracellular calcium
YH Fan, H Chen, A Natarajan, Y Guo, F Harbinski, J Iyasere, W Christ, ...
Bioorganic & medicinal chemistry letters 14 (10), 2547-2550, 2004
Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders
M Naramura, S Nadeau, GA Bhopal Mohapatra, C Mukhopadhyay, ...
Oncotarget 2 (3), 245, 2011
Synthetic Studies toward Aryl-(4-aryl-4H-[1,2,4]triazole-3-yl)-amine from 1,3-Diarylthiourea as Urea Mimetics
A Natarajan, Y Guo, H Arthanari, G Wagner, JA Halperin, M Chorev
The Journal of organic chemistry 70 (16), 6362-6368, 2005
Perturbing pro-survival proteins using quinoxaline derivatives: A structure–activity relationship study
R Rajule, VC Bryant, H Lopez, X Luo, A Natarajan
Bioorganic & medicinal chemistry 20 (7), 2227-2234, 2012
Micellar formulation of indocyanine green for phototherapy of melanoma
V Mundra, Y Peng, S Rana, A Natarajan, RI Mahato
Journal of Controlled Release 220, 130-140, 2015
Microwave-assisted cleavage of phosphate, phosphonate and phosphoramide esters
GDK Kumar, D Saenz, GL Lokesh, A Natarajan
Tetrahedron letters 47 (35), 6281-6284, 2006
Poly-L-proline type II peptide mimics based on the 3-azabicyclo [3.1. 0] hexane system
A Mamai, R Zhang, A Natarajan, JS Madalengoitia
The Journal of organic chemistry 66 (2), 455-460, 2001
Inhibition of BRCT (BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal …
ZY Pessetto, Y Yan, T Bessho, A Natarajan
Breast cancer research and treatment 134 (2), 511-517, 2012
Dual-fluorophore quantitative high-throughput screen for inhibitors of BRCT–phosphoprotein interaction
A Simeonov, A Yasgar, A Jadhav, GL Lokesh, C Klumpp, S Michael, ...
Analytical biochemistry 375 (1), 60-70, 2008
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20